Clinical Cardiology Alert – July 1, 2003
July 1, 2003
View Issues
-
Spinonolactone Post Myocardial Infarction
Since aldosterone is extracted by the heart following acute myocardial infarction (MI), this group of investigators from Japan hypothesized that blocking its action may attenuate postinfarction remodeling. -
Restenosis in Drug-Eluting Stents
The pattern of restenosis in sirolimus-eluting stents is focal and mainly inside the stent. -
Combined Cardiac Resynchronization and Implantable Cardioversion Defibrillator
Cardiac resynchronization therapy improves quality of life and New York Heart Association Functional class in patients with moderate-to-severe heart failure, wide QRS durations, and indications for an ICD. -
AMIOVIRT Trial
Data do not support early implantation of prophylactic ICDs in patients with nonischemic cardiomyopathy. -
Vasopressin for Vasodilatory Shock
The combined infusion of AVP and NE was superior to NE alone in catecholamine-resistant vasodilatory shock. -
New Hypertension Guidelines: JNC-7
A new classification of blood pressure in adults is suggested, with normal blood pressure (BP) as < 120 mm Hg and < 80 mm Hg. -
Pharmacology Watch: HRT, Estrogen, and Postmenopausal Women: Year-Old WHI Study Continues to Raise Questions
The Women's Health Initiatives (WHI) was halted 1 year ago, but fallout from this landmark study continues. The study was designed to identify the risks or benefits of estrogen plus progesterone vs placebo in healthy postmenopausal women. -
Clinical Briefs in Primary Care Supplement